Parexel takes ‘significant step forward’ in RWE strategy with Shyft Analytics

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/everythingpossible)
(Image: Getty/everythingpossible)

Related tags: RWE, Parexel, Medidata, Data management, Real world data

Parexel is adopting Medidata’s Shyft Analytics platform to bolster its real-world evidence generation and outcomes research offering to biopharmaceutical and medical device clients.

Shyft Analytics is a Medidata Solutions company, which this week has signed a strategic partnership agreement with Parexel, a global biopharmaceutical services provider.

Michelle Hoiseth, chief data officer, Parexel​, said the new collaboration with Shyft – as well as its recent partnership with Datavant​, which enhances the company’s data-linking capabilities – is a “significant step forward”​ in its approach to help sponsors leverage real-world data.

“The availability of real-world data is growing, however, innovative analytics methods and technology are needed in order gain insights from that data,”​ she told us.

“Leveraging Shyft’s Quantum RWE platform significantly advances our dynamic modeling capability and reduces the time to analyses in our healthcare data-based strategy, design, and modeling.”

With Shyft’s technology, Parexel will be able to perform at-scale analyses, including cohort modeling, trial feasibility assessment, and large-scale observational studies – “research that will have broad impact across the drug development and market access spectrum,”​ said Hoiseth.

According to a study​ commissioned by Parexel and published by the Economist Intelligence Unit (EIU), the likelihood of new product launch increased by 21% for trials using real-world data.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars